ClinicalTrials.gg
RecruitingNCT07079995Updated Jul 10, 2026

Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial

An interventional study of Mentoring program and Waitlist in Cardiovascular Diseases, Physical Activity and Nutrition, sponsored by Texas A&M University. Recruiting at 1 site in United States. Open to participants aged 8 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-10.

Sponsored by Texas A&M University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
900
Allocation
Randomized
Ages
8 Years to 16 Years
Sex
All
01

Study summary

Healthy School Recognized Campus is a Texas A\&M AgriLife Extension initiative that supports the delivery of school-based physical activity and nutrition programs for diverse youth across Texas. The purpose of this study is to conduct a type 2 hybrid implementation-effectiveness, cluster dual randomized controlled trial (DRCT) to assess both Healthy School Recognized Campus (HSRC) and the mentoring program.

Read the detailed description

This study uses a type 2 hybrid implementation-effectiveness, cluster dual randomized controlled trial (DRCT). DRCTs include two randomized controlled trials within the same study: one testing an intervention (i.e., HSRC) and one testing an implementation strategy (i.e., the mentoring program).

Schools in Central and East Texas (n=20) of similar socio-economic status will be randomized at baseline to either the HSRC condition or the Waitlist Control condition. In the HSRC condition, schools will attempt to deliver youth and adult physical activity or nutrition programs. In the Waitlist Control condition, schools will not add or remove any current physical activity and/or healthy eating programs, and will receive HSRC the next school year. Schools will also be randomized to receive the mentoring program or standard implementation immediately or after being a waitlist control.

Aim 1: Determine the effectiveness of the HSRC initiative compared to a control group on BMI-Z score, physical activity, and skin carotenoids (i.e., fruit and vegetable intake).

For Aim 1, the investigators will compare outcomes in 10 Texas schools that receive HSRC with 10 Waitlist Control communities.

Aim 2: Determine the impact of the mentoring program compared to standard implementation on short-term (acceptability, appropriateness, feasibility) and long-term (number of students reached, total dosage delivered) implementation outcomes.

For Aim 2, the investigators will compare outcomes in 10 Texas schools that receive the mentoring program with 10 that receive standard implementation.

02

Conditions studied

  • Cardiovascular Diseases
  • Physical Activity
  • Nutrition
03

In context

Cardiovascular Diseases

5,368 studies on the registry are indexed under Cardiovascular Diseases; 939 are open to participants now.

This study's planned enrollment of 900 is above the median of 100 across 3,084 interventional studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

Texas A&M University is the lead sponsor of 123 studies on the registry; 23 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 2 (29%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

School Inclusion Criteria:

  • located in Central and East Texas
  • Public school

Student Inclusion Criteria

  • enrolled in the 4th, 5th, 6th, 7th, 8th, or 9th grade
  • able to read, speak, and write in English

Student Exclusion Criteria:

  • any motor or cognitive impairments or other health conditions that would prevent them from completing a physical assessment
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
900 participants (estimated)

Study arms

  • No intervention
    HSRC + Standard Implementation

    Participants in this group will receive HSRC in the first year of enrollment with standard implementation. \[schools (n=5), participants (n=225)\]

  • Experimental
    HSRC + Mentoring Program

    Participants in this group will receive HSRC in the first year of enrollment with the mentoring program. \[schools (n=5), participants (n=225)\]

    Behavioral: Mentoring program

  • Experimental
    Waitlist Control + HSRC + Standard Implementation

    Participants in this group will receive HSRC with standard implementation one year after enrollment. \[schools (n=5), participants (n=225)\]

    Behavioral: Waitlist

  • Experimental
    Waitlist Control + HSRC + Mentoring Program

    Participants in this group will receive HSRC with the mentoring program one year after enrollment. \[schools (n=5), participants (n=225)\]

    Behavioral: Mentoring program · Behavioral: Waitlist

Interventions

  • BehavioralMentoring program

    Schools in this group will participate in meetings and receive newsletters to help with program implementation.

  • BehavioralWaitlist

    Schools in this group will wait 1 year to receive HSRC. Schools will not add or remove any current physical activity and/or healthy eating programs.

06

What researchers measure

Primary outcomes

  1. Body mass index (BMI)

    Weight will be measured with a scale (in pounds), and height will be measured using a stadiometer (in inches). Weight and height will be combined to report BMI as follows, BMI = (weight (lb)/height (inches)2) x 703.

    Time frame: Baseline, 9 months

  2. Acceptability of the HSRC program

    Acceptability will be assessed using the Acceptability of Intervention Measure (AIM) 4-item survey. The survey will be used to assess program implementers' perceived acceptability of the program (i.e., This program seems fine.)

    Time frame: Baseline, 9 months

  3. Appropriateness of the HSRC program

    Appropriateness will be assessed with the Intervention Appropriateness Measure (IAM) 4-item survey. The survey will assess program implementers' perception of the appropriateness of the program (e.g., This program seems suitable.)

    Time frame: Baseline, 9 months

  4. Feasibility of the HSRC program

    Feasibility will be assessed using the Feasibility of Intervention Measure (FIM) 4-item survey. The survey will assess program implementers' perception of the program's feasibility (e.g., This program seems doable.)

    Time frame: Baseline, 9 months

Secondary outcomes

  1. Concentration of subdermal carotenoids

    The concentration of subdermal carotenoids will assess the changes in fruit and vegetable consumption using the Veggie Meter: A non-invasive, portable machine that measures subdermal carotenoid levels using resonance Raman spectroscopy.

    Time frame: Baseline, 9 months

  2. Accelerometer-derived physical activity estimation

    Physical activity will be measured using Actigraph accelerometers. Measurements will include light physical activity (PA), moderate PA, moderate to vigorous PA, and vigorous PA.

    Time frame: Baseline, 9 months

  3. Number of students reached

    Time frame: Baseline, 9 months

  4. Total program dosage delivered

    Time frame: Baseline, 9 months

Other outcomes

  1. Blood pressure

    Blood pressure (systolic and diastolic) will be measured with two numbers using an automated Omron sphygmomanometer.

    Time frame: Baseline, 9 months

  2. Physical fitness capacity estimation

    Physical fitness will be measured using the FitnessGram PACER multistage aerobic capacity test: Children will run back and forth 20 meters, with an initial running speed of 8.5 km/hour and a progressive 0.5-km/hour increase in running speed every minute. As the test continues it becomes progressively harder. The number of laps completed is used to estimate children's physical fitness physical fitness.

    Time frame: Baseline, 9 months

  3. Waist circumference

    Waist circumference will be measured at the midpoint between the floating rib and iliac crest using a tape measure.

    Time frame: Baseline, 9 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Schaefers A, Beattie CM, de Mello GT, George A, Marstall K, Gardner J, Szeszulski J. Healthy school recognized campus: design and methodology of a hybrid type 2 implementation-effectiveness cluster randomized trial. Implement Sci. 2026 Feb 5;21(1):19. doi: 10.1186/s13012-026-01487-2. PubMed 41645239 ↗

Individual participant data

Plan to share: Yes — Data will include student biometrics, student surveys, and implementer surveys. Student biometrics will include assessments of height, weight, physical activity, fruit and vegetable consumption, cardiovascular fitness, and markers of cardiometabolic health (e.g., blood pressure). Student surveys will include assessment of student demographics, physical activity, healthy eating, and other important outcomes (e.g., positive youth development). Implementer surveys will include demographics and assessment of implementation outcomes as they relate to programs that are a part of healthy school recognized campus.

Time frame: start: 3/31/2028

Access criteria: Researchers can access through ClinicalTrials.gov or Open Science Framework (general)

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Jun 2028, 33 months after the start.

Of 1,077 non-industry interventional studies with no phase under Cardiovascular Diseases, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 33 months is above that.

Counting every sponsor, half of 1,216 studies reached it within 26 months; a quarter within 12 and three quarters within 49.

Cardiovascular Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 1, 2025
First posted
Jul 23, 2025
StartActual
Sep 1, 2025
Primary completionEst.
Jun 30, 2028
CompletionEst.
Jun 30, 2028
Last update
Jul 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07079995
Collaborators
American Heart Association
Responsible party
Sponsor
First posted
Jul 23, 2025
Start date
Sep 1, 2025
Primary completion
Jun 30, 2028 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
Jul 10, 2026

Study contacts

Jacob Szeszulski
Contact
jacob.szeszulski@agnet.tamu.edu
972-952-9202
Jacob Szeszulski
principal investigator · Institute for Advancing Health through Agriculture

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion